Trademark Overview
On Monday, July 7, 2025, a trademark application was filed for NEUROCEUTICAL with the United States Patent and Trademark Office. The USPTO has given the NEUROCEUTICAL trademark a serial number of 99270595. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 7, 2025. The NEUROCEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and biologically active compositions incorporating neurotechnology for cognitive, neurological, or physiological modulation. Includes compounds or preparations delivered by ingestion, injection, inhalation, topical contact, implantation, or passive exposure through air, water, food, or skin. Covers formulations responsive to electromagnetic fields, radiofrequency, or wireless signals, including current and future networks such as 5G, 6G, or satellite-linked systems. Neuroceuticals may include nanotechnology, such as nanoparticles, nanobots, or neural dust, designed to interface with the human nervous system. Includes both voluntary and passive administration, and may function independently or in combination with AI, biometric systems, or remote neural monitoring platforms.
